Which factors contribute to secondary hyperparathyroidism in chronic kidney disease?

• A. Phosphate retention, hypocalcemia, reduced calcitriol synthesis, leading to PTH elevation.
• B. Hypercalcemia due to excessive calcitriol.
• C. Excess calcitriol synthesis leading to PTH suppression.
• D. Vitamin D deficiency without PTH involvement.

Answer: (A)

Secondary hyperparathyroidism in chronic kidney disease happens because the kidneys can’t excrete phosphate well and can’t make enough calcitriol. Phosphate builds up in the blood and raises the calcium-phosphate product, which lowers the amount of free calcium. At the same time, reduced calcitriol synthesis means less calcium is absorbed from the gut, further lowering serum calcium. The parathyroid glands respond to this hypocalcemia and low calcitriol by increasing PTH secretion, and with ongoing stimulation they enlarge. This combination—phosphate retention, hypocalcemia, and reduced calcitriol production—drives the rise of PTH that characterizes secondary hyperparathyroidism in CKD.

The other scenarios don’t fit the typical CKD picture: excess calcitriol would raise calcium and suppress PTH; CKD usually involves reduced calcitriol rather than excess; vitamin D deficiency alone would raise PTH only if calcium and calcitriol were involved, but CKD-related hyperparathyroidism is driven primarily by phosphate retention and low calcitriol.